Ju-Young Shin, PharmD, PhD

School of Pharmacy, Sungkyunkwan University, Suwon, South Korea, Republic of Korea

Disclosure information not submitted.

Presentation(s):

• 1A-05 - End-stage renal diseases associated with the use of SGLT2 inhibitors versus GLP-1 receptor agonists among individuals with metabolic dysfunction-associated steatotic liver disease: A nationwide cohort study

  Sunday, August 24, 2025
  11:30 AM - 11:45 AM ET

• 1B - COVID-19 and recovery

  Sunday, August 24, 2025
  10:30 AM - 12:00 PM ET

• 1C-03 - Oral Corticosteroids During Pregnancy and Gestational Diabetes Mellitus: A Sequential Landmark Analysis

  Sunday, August 24, 2025
  11:00 AM - 11:15 AM ET

• 1E-05 - Risk of Major Bleeding with Concomitant Use of Selective Serotonin Reuptake Inhibitors and Antithrombotics: a Nationwide Case-Case-Time-Control Study

  Sunday, August 24, 2025
  11:30 AM - 11:45 AM ET

• 1F-05 - Development and validation of gestational age estimation algorithms for non-live births in administrative healthcare databases

  Sunday, August 24, 2025
  11:30 AM - 11:45 AM ET

• 2C - Innovative Methods and Designs in Vaccine Research: Advancing Precision and Impact

  Sunday, August 24, 2025
  3:30 PM - 5:00 PM ET

• 2G-02 - Maternal Opioid Use During Lactation and the Risk of Adverse Infant Outcomes: A Nationwide Cohort Study Using the National Health Screening Program for Infants

  Sunday, August 24, 2025
  3:45 PM - 4:00 PM ET

• 3B-06 - Timing of antidiabetic medication initiation and risk of major adverse cardiovascular events and mortality: A target trial emulation with clone-censor-weight approach

  Monday, August 25, 2025
  9:30 AM - 9:45 AM ET

• 3G-06 - Periconceptional Statin Discontinuation, Maternal Cardiovascular Events, and Pregnancy Outcomes: A Target Trial Emulation

  Monday, August 25, 2025
  9:30 AM - 9:45 AM ET

• SW-3C - How should we interpret self-controlled study designs in the era of causal inference?

  Monday, August 25, 2025
  1:00 PM - 2:30 PM ET

• 4F-06 - Antiemetic Use During Pregnancy and Child Neurodevelopmental Disorders: A Nationwide Birth Cohort Study

  Monday, August 25, 2025
  5:30 PM - 5:45 PM ET

• SW-4F - Approaches to Time-Zero and Time-Related Bias in External Control Arm Study Design: Methodological Considerations and Applications

  Tuesday, August 26, 2025
  10:30 AM - 12:00 PM ET

• 6C-05 - Aspirin use and the risk of hepatic events in patients with metabolic dysfunction-associated steatotic liver disease: A target trial emulation with clone-censor-weight approach

  Tuesday, August 26, 2025
  2:30 PM - 2:45 PM ET

• 6G-05 - Timing of SGLT2 inhibitors Initiation on Clinical Complications in Diabetic Metabolic Dysfunction-Associated Steatotic Liver Disease: A Target Trial Emulation Study With a Clone-Censor-Weight Approach

  Tuesday, August 26, 2025
  2:30 PM - 2:45 PM ET